|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.385
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.338
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.327
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.279
|
|
|
|
lipid transport
|
GO:0006869 |
98 |
0.278
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.246
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.232
|
|
|
|
regulation of cell cycle
|
GO:0051726 |
281 |
0.200
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.198
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.197
|
|
|
|
immune effector process
|
GO:0002252 |
321 |
0.192
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.191
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.172
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.162
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.157
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.156
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.153
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.151
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.144
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.141
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.136
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.133
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.123
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.119
|
|
|
|
blood vessel morphogenesis
|
GO:0048514 |
285 |
0.117
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.115
|
|
|
|
leukocyte migration
|
GO:0050900 |
124 |
0.115
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.113
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.111
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.111
|
|
|
|
peptidyl tyrosine modification
|
GO:0018212 |
145 |
0.106
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.106
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.103
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.102
|
|
|
|
atrioventricular node cell differentiation
|
GO:0060922 |
2 |
0.101
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.096
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.095
|
|
|
|
leukocyte proliferation
|
GO:0070661 |
172 |
0.093
|
|
|
|
chondrocyte differentiation
|
GO:0002062 |
72 |
0.092
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.091
|
|
|
|
peptidyl tyrosine phosphorylation
|
GO:0018108 |
143 |
0.091
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.090
|
|
|
|
digestive tract development
|
GO:0048565 |
190 |
0.087
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.086
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.086
|
|
|
|
b cell differentiation
|
GO:0030183 |
78 |
0.084
|
|
|
|
t cell proliferation
|
GO:0042098 |
120 |
0.084
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.081
|
|
|
|
interleukin 5 secretion
|
GO:0072603 |
2 |
0.079
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.079
|
|
|
|
regulation of homeostatic process
|
GO:0032844 |
182 |
0.078
|
|
|
|
regulation of map kinase activity
|
GO:0043405 |
120 |
0.078
|
|
|
|
defense response to virus
|
GO:0051607 |
68 |
0.077
|
|
|
|
macromolecule catabolic process
|
GO:0009057 |
281 |
0.076
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.075
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.074
|
|
|
|
polysaccharide metabolic process
|
GO:0005976 |
39 |
0.074
|
|
|
|
metanephros development
|
GO:0001656 |
79 |
0.073
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.072
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.072
|
|
|
|
glial cell differentiation
|
GO:0010001 |
131 |
0.072
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.072
|
|
|
|
regulation of interleukin 5 secretion
|
GO:2000662 |
2 |
0.070
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.069
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.068
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.068
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.066
|
|
|
|
negative regulation of interleukin 5 secretion
|
GO:2000663 |
1 |
0.065
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.064
|
|
|
|
digestive system development
|
GO:0055123 |
200 |
0.063
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.063
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.062
|
|
|
|
regulation of cardioblast differentiation
|
GO:0051890 |
3 |
0.062
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.062
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.061
|
|
|
|
hepaticobiliary system development
|
GO:0061008 |
67 |
0.061
|
|
|
|
regulation of cell motility
|
GO:2000145 |
236 |
0.060
|
|
|
|
respiratory tube development
|
GO:0030323 |
167 |
0.060
|
|
|
|
sensory perception of sound
|
GO:0007605 |
97 |
0.060
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
92 |
0.058
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.057
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.057
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.057
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.057
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.057
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.055
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.055
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.054
|
|
|
|
positive regulation of leukocyte proliferation
|
GO:0070665 |
73 |
0.053
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.053
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.053
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.052
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.052
|
|
|
|
inorganic ion transmembrane transport
|
GO:0098660 |
234 |
0.052
|
|
|
|
cellular divalent inorganic cation homeostasis
|
GO:0072503 |
127 |
0.052
|
|
|
|
negative regulation of interleukin 13 secretion
|
GO:2000666 |
1 |
0.052
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.052
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.051
|
|
|
|
negative regulation of interleukin 13 production
|
GO:0032696 |
2 |
0.051
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.051
|
|
|
|
calcium mediated signaling
|
GO:0019722 |
46 |
0.051
|
|
|
|
spermatid differentiation
|
GO:0048515 |
115 |
0.050
|
|
|
|
regulation of interleukin 13 secretion
|
GO:2000665 |
2 |
0.050
|
|
|
|
positive regulation of transcription via serum response element binding
|
GO:0010735 |
1 |
0.049
|
|
|
|
interspecies interaction between organisms
|
GO:0044419 |
83 |
0.049
|
|
|
|
rhythmic process
|
GO:0048511 |
174 |
0.049
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.048
|
|
|
|
negative regulation of t cell cytokine production
|
GO:0002725 |
1 |
0.048
|
|
|
|
symbiosis encompassing mutualism through parasitism
|
GO:0044403 |
83 |
0.047
|
|
|
|
regulation of metal ion transport
|
GO:0010959 |
106 |
0.047
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
195 |
0.047
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.047
|
|
|
|
kidney development
|
GO:0001822 |
213 |
0.047
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.046
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.046
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.046
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
174 |
0.045
|
|
|
|
tissue homeostasis
|
GO:0001894 |
115 |
0.045
|
|
|
|
regulation of extrinsic apoptotic signaling pathway
|
GO:2001236 |
77 |
0.045
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.045
|
|
|
|
negative regulation of interleukin 5 production
|
GO:0032714 |
4 |
0.045
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
126 |
0.045
|
|
|
|
adult behavior
|
GO:0030534 |
135 |
0.044
|
|
|
|
lipid localization
|
GO:0010876 |
126 |
0.044
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.044
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.044
|
|
|
|
t helper 2 cell cytokine production
|
GO:0035745 |
4 |
0.043
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
232 |
0.043
|
|
|
|
microtubule based process
|
GO:0007017 |
236 |
0.043
|
|
|
|
cellular component assembly involved in morphogenesis
|
GO:0010927 |
139 |
0.043
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.043
|
|
|
|
hexose metabolic process
|
GO:0019318 |
98 |
0.043
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.043
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.042
|
|
|
|
multicellular organism growth
|
GO:0035264 |
161 |
0.042
|
|
|
|
response to peptide hormone
|
GO:0043434 |
127 |
0.041
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.041
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.041
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.040
|
|
|
|
neuroepithelial cell differentiation
|
GO:0060563 |
37 |
0.040
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.040
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.040
|
|
|
|
glycoprotein biosynthetic process
|
GO:0009101 |
89 |
0.039
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.039
|
|
|
|
liver development
|
GO:0001889 |
66 |
0.039
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.039
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.039
|
|
|
|
regulation of lipid transport
|
GO:0032368 |
36 |
0.039
|
|
|
|
positive regulation of renal sodium excretion
|
GO:0035815 |
2 |
0.038
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.038
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.038
|
|
|
|
angiogenesis
|
GO:0001525 |
201 |
0.038
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
88 |
0.038
|
|
|
|
urogenital system development
|
GO:0001655 |
261 |
0.038
|
|
|
|
lung cell differentiation
|
GO:0060479 |
30 |
0.038
|
|
|
|
cerebral cortex development
|
GO:0021987 |
86 |
0.038
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.038
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.038
|
|
|
|
positive regulation of cell migration
|
GO:0030335 |
109 |
0.038
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.037
|
|
|
|
cellular response to hormone stimulus
|
GO:0032870 |
150 |
0.037
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.037
|
|
|
|
regulation of lateral mesodermal cell fate specification
|
GO:0048378 |
2 |
0.037
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
159 |
0.037
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.037
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.036
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.036
|
|
|
|
exocrine system development
|
GO:0035272 |
45 |
0.036
|
|
|
|
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains
|
GO:0002460 |
145 |
0.036
|
|
|
|
cerebral cortex tangential migration using cell axon interactions
|
GO:0021824 |
3 |
0.036
|
|
|
|
male gonad development
|
GO:0008584 |
88 |
0.036
|
|
|
|
negative regulation of nervous system development
|
GO:0051961 |
156 |
0.036
|
|
|
|
lung development
|
GO:0030324 |
164 |
0.036
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.035
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.035
|
|
|
|
chemotaxis
|
GO:0006935 |
247 |
0.035
|
|
|
|
somatotropin secreting cell differentiation
|
GO:0060126 |
4 |
0.035
|
|
|
|
pancreas development
|
GO:0031016 |
57 |
0.035
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.034
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.034
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.034
|
|
|
|
response to growth factor
|
GO:0070848 |
198 |
0.034
|
|
|
|
spermatid development
|
GO:0007286 |
108 |
0.033
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
52 |
0.033
|
|
|
|
osteoclast differentiation
|
GO:0030316 |
62 |
0.033
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.033
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.033
|
|
|
|
negative chemotaxis
|
GO:0050919 |
14 |
0.032
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.032
|
|
|
|
axon guidance
|
GO:0007411 |
141 |
0.032
|
|
|
|
circadian temperature homeostasis
|
GO:0060086 |
2 |
0.032
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.031
|
|
|
|
labyrinthine layer blood vessel development
|
GO:0060716 |
21 |
0.031
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.031
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.031
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.031
|
|
|
|
glucan metabolic process
|
GO:0044042 |
32 |
0.031
|
|
|
|
sphingolipid metabolic process
|
GO:0006665 |
45 |
0.031
|
|
|
|
carbohydrate biosynthetic process
|
GO:0016051 |
74 |
0.031
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.030
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
144 |
0.030
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.030
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
68 |
0.030
|
|
|
|
regulation of lymphocyte activation
|
GO:0051249 |
240 |
0.030
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.029
|
|
|
|
bone remodeling
|
GO:0046849 |
53 |
0.029
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.029
|
|
|
|
glycogen metabolic process
|
GO:0005977 |
32 |
0.029
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.029
|
|
|
|
mesenchyme development
|
GO:0060485 |
152 |
0.029
|
|
|
|
regulation of hormone secretion
|
GO:0046883 |
88 |
0.029
|
|
|
|
cellular response to growth factor stimulus
|
GO:0071363 |
197 |
0.029
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.028
|
|
|
|
positive regulation of map kinase activity
|
GO:0043406 |
84 |
0.028
|
|
|
|
tachykinin receptor signaling pathway
|
GO:0007217 |
1 |
0.028
|
|
|
|
directional locomotion
|
GO:0033058 |
3 |
0.028
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.028
|
|
|
|
lung epithelium development
|
GO:0060428 |
37 |
0.028
|
|
|
|
inorganic cation transmembrane transport
|
GO:0098662 |
207 |
0.028
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.027
|
|
|
|
regulation of reproductive process
|
GO:2000241 |
66 |
0.027
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.027
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.027
|
|
|
|
positive regulation of cyclic nucleotide biosynthetic process
|
GO:0030804 |
24 |
0.027
|
|
|
|
ventricular cardiac myofibril assembly
|
GO:0055005 |
3 |
0.027
|
|
|
|
natural killer cell activation
|
GO:0030101 |
44 |
0.027
|
|
|
|
glycoprotein metabolic process
|
GO:0009100 |
116 |
0.027
|
|
|
|
positive regulation of cardioblast differentiation
|
GO:0051891 |
3 |
0.027
|
|
|
|
regulation of ossification
|
GO:0030278 |
112 |
0.026
|
|
|
|
regulation of t cell activation
|
GO:0050863 |
170 |
0.026
|
|
|
|
muscle cell migration
|
GO:0014812 |
19 |
0.026
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.026
|
|
|
|
stem cell maintenance
|
GO:0019827 |
130 |
0.026
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.026
|
|
|
|
smoothened signaling pathway
|
GO:0007224 |
105 |
0.025
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.025
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.025
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.025
|
|
|
|
negative regulation of neuron apoptotic process
|
GO:0043524 |
92 |
0.025
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.025
|
|
|
|
protein catabolic process
|
GO:0030163 |
221 |
0.025
|
|
|
|
response to insulin
|
GO:0032868 |
100 |
0.025
|
|
|
|
pituitary gland development
|
GO:0021983 |
38 |
0.025
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
193 |
0.025
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.025
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.024
|
|
|
|
proepicardium development
|
GO:0003342 |
2 |
0.024
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.024
|
|
|
|
transmembrane receptor protein serine threonine kinase signaling pathway
|
GO:0007178 |
194 |
0.024
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.024
|
|
|
|
dna metabolic process
|
GO:0006259 |
303 |
0.024
|
|
|
|
tissue remodeling
|
GO:0048771 |
102 |
0.024
|
|
|
|
homeostasis of number of cells
|
GO:0048872 |
210 |
0.024
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.024
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.024
|
|
|
|
divalent metal ion transport
|
GO:0070838 |
172 |
0.024
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
negative regulation of response to wounding
|
GO:1903035 |
77 |
0.024
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.024
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.023
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.023
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.023
|
|
|
|
b cell activation
|
GO:0042113 |
161 |
0.023
|
|
|
|
establishment of organelle localization
|
GO:0051656 |
122 |
0.023
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.023
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.023
|
|
|
|
embryonic placenta morphogenesis
|
GO:0060669 |
25 |
0.023
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.023
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.023
|
|
|
|
wnt signaling pathway
|
GO:0016055 |
188 |
0.023
|
|
|
|
spinal cord oligodendrocyte cell fate specification
|
GO:0021530 |
3 |
0.022
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.022
|
|
|
|
branching morphogenesis of an epithelial tube
|
GO:0048754 |
159 |
0.022
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.022
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.022
|
|
|
|
male sex differentiation
|
GO:0046661 |
109 |
0.022
|
|
|
|
outflow tract morphogenesis
|
GO:0003151 |
53 |
0.022
|
|
|
|
interaction with host
|
GO:0051701 |
22 |
0.022
|
|
|
|
myeloid cell differentiation
|
GO:0030099 |
233 |
0.022
|
|
|
|
atrial cardiac muscle cell development
|
GO:0055014 |
2 |
0.022
|
|
|
|
white fat cell proliferation
|
GO:0070343 |
2 |
0.022
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.022
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
84 |
0.022
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.022
|
|
|
|
positive regulation of voltage gated calcium channel activity
|
GO:1901387 |
2 |
0.022
|
|
|
|
cellular metal ion homeostasis
|
GO:0006875 |
151 |
0.021
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.021
|
|
|
|
monosaccharide metabolic process
|
GO:0005996 |
106 |
0.021
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.021
|
|
|
|
positive regulation of mitotic cell cycle
|
GO:0045931 |
41 |
0.021
|
|
|
|
diencephalon development
|
GO:0021536 |
63 |
0.021
|
|
|
|
energy reserve metabolic process
|
GO:0006112 |
39 |
0.021
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.021
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
167 |
0.021
|
|
|
|
positive regulation of peptide secretion
|
GO:0002793 |
33 |
0.021
|
|
|
|
corticosterone secretion
|
GO:0035934 |
3 |
0.021
|
|
|
|
positive regulation of hormone secretion
|
GO:0046887 |
38 |
0.021
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.021
|
|
|
|
cd4 positive alpha beta t cell cytokine production
|
GO:0035743 |
4 |
0.020
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.020
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.020
|
|
|
|
negative regulation of lymphocyte activation
|
GO:0051250 |
91 |
0.020
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.020
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.020
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.020
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.020
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.020
|
|
|
|
septum transversum development
|
GO:0003343 |
2 |
0.020
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.020
|
|
|
|
positive regulation of chemotaxis
|
GO:0050921 |
38 |
0.020
|
|
|
|
clara cell differentiation
|
GO:0060486 |
4 |
0.020
|
|
|
|
cartilage development
|
GO:0051216 |
140 |
0.020
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.020
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.019
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
271 |
0.019
|
|
|
|
viral life cycle
|
GO:0019058 |
36 |
0.019
|
|
|
|
bone mineralization
|
GO:0030282 |
54 |
0.019
|
|
|
|
regulation of axon guidance
|
GO:1902667 |
13 |
0.019
|
|
|
|
regulation of polysaccharide metabolic process
|
GO:0032881 |
13 |
0.019
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.019
|
|
|
|
positive regulation of homeostatic process
|
GO:0032846 |
64 |
0.019
|
|
|
|
negative regulation of ossification
|
GO:0030279 |
49 |
0.019
|
|
|
|
detection of stimulus
|
GO:0051606 |
84 |
0.019
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.019
|
|
|
|
regulation of leukocyte proliferation
|
GO:0070663 |
121 |
0.019
|
|
|
|
glycosylation
|
GO:0070085 |
62 |
0.019
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.019
|
|
|
|
lung epithelial cell differentiation
|
GO:0060487 |
29 |
0.019
|
|
|
|
regulation of tissue remodeling
|
GO:0034103 |
38 |
0.019
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.019
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.019
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.019
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.019
|
|
|
|
mitotic nuclear division
|
GO:0007067 |
48 |
0.019
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
147 |
0.019
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.019
|
|
|
|
positive regulation of activin receptor signaling pathway
|
GO:0032927 |
3 |
0.018
|
|
|
|
adaptive immune response
|
GO:0002250 |
155 |
0.018
|
|
|
|
negative regulation of cell fate specification
|
GO:0009996 |
4 |
0.018
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.018
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.018
|
|
|
|
acetate ester transport
|
GO:1901374 |
2 |
0.018
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.018
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.018
|
|
|
|
type b pancreatic cell proliferation
|
GO:0044342 |
10 |
0.018
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.018
|
|
|
|
regulation of cellular response to growth factor stimulus
|
GO:0090287 |
82 |
0.018
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.018
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.017
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.017
|
|
|
|
regulation of protein secretion
|
GO:0050708 |
82 |
0.017
|
|
|
|
membrane lipid metabolic process
|
GO:0006643 |
53 |
0.017
|
|
|
|
sensory perception of pain
|
GO:0019233 |
47 |
0.017
|
|
|
|
endoderm development
|
GO:0007492 |
45 |
0.017
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.017
|
|
|
|
polysaccharide biosynthetic process
|
GO:0000271 |
20 |
0.017
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.017
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
33 |
0.017
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
59 |
0.017
|
|
|
|
protein glycosylation
|
GO:0006486 |
55 |
0.017
|
|
|
|
cell activation involved in immune response
|
GO:0002263 |
126 |
0.017
|
|
|
|
positive regulation of lymphocyte proliferation
|
GO:0050671 |
70 |
0.017
|
|
|
|
protein import
|
GO:0017038 |
101 |
0.017
|
|
|
|
atrial cardiac muscle cell differentiation
|
GO:0055011 |
2 |
0.017
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.017
|
|
|
|
purkinje myocyte differentiation
|
GO:0003168 |
1 |
0.017
|
|
|
|
atrioventricular node cell development
|
GO:0060928 |
2 |
0.017
|
|
|
|
neuron migration
|
GO:0001764 |
122 |
0.017
|
|
|
|
neuron projection guidance
|
GO:0097485 |
141 |
0.017
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
22 |
0.017
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.017
|
|
|
|
regulation of t helper 2 cell cytokine production
|
GO:2000551 |
3 |
0.017
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.017
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.017
|
|
|
|
hormone mediated signaling pathway
|
GO:0009755 |
23 |
0.017
|
|
|
|
organ induction
|
GO:0001759 |
21 |
0.016
|
|
|
|
positive regulation of adenylate cyclase activity involved in g protein coupled receptor signaling pathway
|
GO:0010579 |
3 |
0.016
|
|
|
|
bone resorption
|
GO:0045453 |
38 |
0.016
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.016
|
|
|
|
negative regulation of cell activation
|
GO:0050866 |
111 |
0.016
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.016
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
192 |
0.016
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
67 |
0.016
|
|
|
|
connective tissue development
|
GO:0061448 |
179 |
0.016
|
|
|
|
regulation of adaptive immune response
|
GO:0002819 |
90 |
0.016
|
|
|
|
second messenger mediated signaling
|
GO:0019932 |
73 |
0.016
|
|
|
|
hypophysis morphogenesis
|
GO:0048850 |
3 |
0.016
|
|
|
|
regulation of ion transmembrane transporter activity
|
GO:0032412 |
54 |
0.016
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
181 |
0.016
|
|
|
|
glial cell development
|
GO:0021782 |
54 |
0.016
|
|
|
|
harderian gland development
|
GO:0070384 |
2 |
0.016
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.016
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
155 |
0.016
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.016
|
|
|
|
axonogenesis
|
GO:0007409 |
274 |
0.016
|
|
|
|
macrophage differentiation
|
GO:0030225 |
20 |
0.016
|
|
|
|
regulation of erk1 and erk2 cascade
|
GO:0070372 |
71 |
0.016
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.016
|
|
|
|
positive regulation of lymphocyte activation
|
GO:0051251 |
140 |
0.016
|
|
|
|
regulation of nuclear division
|
GO:0051783 |
56 |
0.016
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
61 |
0.016
|
|
|
|
jak stat cascade
|
GO:0007259 |
42 |
0.015
|
|
|
|
protein modification by small protein conjugation or removal
|
GO:0070647 |
207 |
0.015
|
|
|
|
negative regulation of t cell activation
|
GO:0050868 |
65 |
0.015
|
|
|
|
cellular glucan metabolic process
|
GO:0006073 |
32 |
0.015
|
|
|
|
myoblast proliferation
|
GO:0051450 |
11 |
0.015
|
|
|
|
positive regulation of mapk cascade
|
GO:0043410 |
170 |
0.015
|
|
|
|
regulation of translation
|
GO:0006417 |
71 |
0.015
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.015
|
|
|
|
spinal cord oligodendrocyte cell differentiation
|
GO:0021529 |
3 |
0.015
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.015
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.015
|
|
|
|
positive regulation of nervous system development
|
GO:0051962 |
221 |
0.015
|
|
|
|
regulation of glycogen metabolic process
|
GO:0070873 |
13 |
0.015
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.015
|
|
|
|
anion transport
|
GO:0006820 |
177 |
0.015
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.015
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.015
|
|
|
|
regulation of lymphocyte proliferation
|
GO:0050670 |
117 |
0.015
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.015
|
|
|
|
tissue migration
|
GO:0090130 |
68 |
0.015
|
|
|
|
regulation of heart contraction
|
GO:0008016 |
77 |
0.015
|
|
|
|
positive regulation of behavior
|
GO:0048520 |
40 |
0.014
|
|
|
|
translation
|
GO:0006412 |
93 |
0.014
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.014
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.014
|
|
|
|
response to steroid hormone
|
GO:0048545 |
56 |
0.014
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.014
|
|
|
|
mammary gland bud formation
|
GO:0060615 |
2 |
0.014
|
|
|
|
regulation of corticosterone secretion
|
GO:2000852 |
2 |
0.014
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
0 |
0.014
|
|
|
|
erk1 and erk2 cascade
|
GO:0070371 |
77 |
0.014
|
|
|
|
cell fate determination involved in pattern specification
|
GO:0060582 |
1 |
0.014
|
|
|
|
protein import into nucleus
|
GO:0006606 |
95 |
0.014
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.014
|
|
|
|
negative regulation of extrinsic apoptotic signaling pathway
|
GO:2001237 |
45 |
0.014
|
|
|
|
regulation of epithelial cell proliferation
|
GO:0050678 |
141 |
0.014
|
|
|
|
negative regulation of apoptotic signaling pathway
|
GO:2001234 |
104 |
0.014
|
|
|
|
plasma cell differentiation
|
GO:0002317 |
3 |
0.014
|
|
|
|
regulation of symbiosis encompassing mutualism through parasitism
|
GO:0043903 |
52 |
0.014
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.014
|
|
|
|
sperm motility
|
GO:0030317 |
47 |
0.014
|
|
|
|
menarche
|
GO:0042696 |
1 |
0.014
|
|
|
|
hypothalamus cell differentiation
|
GO:0021979 |
8 |
0.014
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
246 |
0.014
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.014
|
|
|
|
glucan biosynthetic process
|
GO:0009250 |
14 |
0.014
|
|
|
|
nuclear import
|
GO:0051170 |
95 |
0.014
|
|
|
|
tyrosine phosphorylation of stat3 protein
|
GO:0042503 |
12 |
0.014
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.014
|
|
|
|
somatostatin signaling pathway
|
GO:0038170 |
2 |
0.014
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.014
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.014
|
|
|
|
regulation of neuron apoptotic process
|
GO:0043523 |
122 |
0.014
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.014
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
184 |
0.014
|
|
|
|
positive regulation of t cell proliferation
|
GO:0042102 |
52 |
0.013
|
|
|
|
phagocytosis
|
GO:0006909 |
66 |
0.013
|
|
|
|
prostate gland epithelium morphogenesis
|
GO:0060740 |
31 |
0.013
|
|
|
|
positive regulation of cytosolic calcium ion concentration
|
GO:0007204 |
65 |
0.013
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.013
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.013
|
|
|
|
gastrulation
|
GO:0007369 |
116 |
0.013
|
|
|
|
adenylate cyclase inhibiting serotonin receptor signaling pathway
|
GO:0007198 |
1 |
0.013
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.013
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.013
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.013
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.013
|
|
|
|
metanephric nephron morphogenesis
|
GO:0072273 |
19 |
0.013
|
|
|
|
carboxylic acid biosynthetic process
|
GO:0046394 |
86 |
0.013
|
|
|
|
nephron tubule morphogenesis
|
GO:0072078 |
68 |
0.013
|
|
|
|
regulation of glutamate secretion
|
GO:0014048 |
3 |
0.013
|
|
|
|
regulation of carbohydrate metabolic process
|
GO:0006109 |
75 |
0.013
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.013
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
224 |
0.013
|
|
|
|
ventral spinal cord interneuron fate determination
|
GO:0060580 |
1 |
0.013
|
|
|
|
interleukin 5 production
|
GO:0032634 |
10 |
0.013
|
|
|
|
insulin secretion
|
GO:0030073 |
89 |
0.013
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.013
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.013
|
|
|
|
mucosal associated lymphoid tissue development
|
GO:0048537 |
12 |
0.013
|
|
|
|
positive regulation of glutamate secretion
|
GO:0014049 |
2 |
0.013
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.013
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.013
|
|
|
|
carbohydrate catabolic process
|
GO:0016052 |
32 |
0.013
|
|
|
|
hindbrain development
|
GO:0030902 |
128 |
0.013
|
|
|
|
regulation of feeding behavior
|
GO:0060259 |
3 |
0.013
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.013
|
|
